Bayer AG has selected Google Cloud to drive early drug discovery that will apply Google Cloud’s Tensorflow Processing Units (TPUs).
Increasing R&D efficiency to accelerate development of impactful medicines for patients in need is central to Bayer’s innovation strategy.
“Partnering with Google Cloud on TPU powered quantum chemistry complements our ambition to work with industry leaders and experts to quickly deliver on digital transformation,” said Bijoy Sagar, chief information and digital transformation officer at Bayer AG.
